Immunocore (IMCR) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Immunocore

NASDAQ: IMCR · Real-Time Price · USD
34.21
-1.07 (-3.05%)
At close: Oct 03, 2025, 3:59 PM
34.00
-0.61%
After-hours: Oct 03, 2025, 04:37 PM EDT

Immunocore Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-20.09M -21.41M -50.87M -60.71M -67.13M -73.34M -69.54M -61.35M -57.44M -45.73M -41.22M -55.41M -91.77M -118.61M -131.52M -111.01M -100.24M -84.49M
Depreciation & Amortization
3.83M 4.05M 4.2M 3.19M 3.82M 4.49M 5.07M 6.26M 6.07M 6.04M 6.13M 6.51M 6.75M 6.88M 7.01M 7.62M 8.06M 8.54M
Stock-Based Compensation
34.75M 34.72M 34.19M 40.82M 42.43M 39.26M 40.5M 32.08M 30M 29.85M 27.05M 28.9M 32.01M 34.68M 35.86M 30.12M 22.71M 16.55M
Other Working Capital
-19.18M -31.6M -3.15M 36.6M 76.13M 61.19M 44.46M 30.23M 34.7M 23.6M -746K -14.79M -28.51M -36.86M -16.81M -17.53M -17.19M -20.16M
Other Non-Cash Items
39.57M 37.73M 46.78M 43.3M -8.12M -3.26M 12.94M 23.68M 23.95M 11.47M -4.2M -5.72M 7.54M 19.33M 18.75M 3.44M 22.07M 38.31M
Deferred Income Tax
n/a n/a n/a 2.21M 2.03M 2.23M 2.52M 2.44M 1.37M -974.29K -2.92M -4.84M -5.72M -6.38M -9.4M -11.77M -13.91M -14.78M
Change in Working Capital
-24.49M -24M -8.25M -5.72M 35.15M 10.29M 5.61M 16.95M 17.97M 14.98M -12.88M -19.86M -28.51M -36.86M -16.81M -18.75M -17.19M -20.16M
Operating Cash Flow
33.58M 31.08M 26.06M 23.09M 8.19M -18.31M -2.86M 20.1M 21.97M 15.81M -25.89M -48.26M -77.55M -100.96M -96.11M -100.35M -78.5M -56.03M
Capital Expenditures
-5.12M -5.04M -5.17M -2.18M -3.44M -4.09M -6.71M -7.44M -5.75M -5.11M -2.2M -1.15M -1.13M -926K -1.01M -1.08M -1.36M -1.87M
Cash Acquisitions
44.02K 44.02K 44.02K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-29.89M -350M -350M -350M -350.11M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
10M 10M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-109.7K -18 -18 1.36M 6.16M 10.45M 13.02M 13.32M 9.22M 4.95M 2.39M 743K 374K 401K 641K 2.79M 3.55M 3.69M
Investing Cash Flow
-25.08M -345M -355.13M -350.82M -347.39M 6.37M 6.31M 5.88M 3.47M -161.01K 193K -404K -753K -525K -367K 1.71M 2.19M 1.83M
Debt Repayment
-400.87M -401.64M 856.03K 404.72M 403.09M 403.86M 1.36M -1.35M -2.17M -2.86M -3.62M -3.22M -3.27M -3.37M -3.42M 46.91M 46.7M 46.36M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
348.76M 348.45M 336.22M -14.2M -15.33M -5.66M 12.72M 8.16M 12.45M 3.29M -3.42M -1.58M -3.31M -4.27M -20.05M -10.63M -10.43M -9.57M
Financial Cash Flow
-45.09M -49.58M 343.88M 403.11M 410.72M 420.86M 27.92M 19.01M 128.71M 118.86M 114.45M 113.58M -5M -6.07M 204.63M 298.65M 298.65M 299.17M
Net Cash Flow
-17.05M -355.98M 13.11M 93.54M 87.05M 421.06M 36.95M 23.9M 136.74M 132.77M 94.65M 90.64M -70.81M -107.23M 108.17M 199.86M 222.06M 244.71M
Free Cash Flow
28.45M 26.04M 20.89M 26.98M 10.82M -16.32M -3.49M 12.66M 16.22M 10.7M -28.09M -49.4M -78.68M -101.89M -97.12M -101.43M -79.86M -57.9M